New: NCI-funded clinical trial search
Mednet Logo

In suspected rare vascular liver disease, what are the highest-yield clinical/imaging “red flags” that should trigger mandatory second review by an expert radiologist (or structured second-read pathway), and how would you set that trigger threshold to maximize diagnostic yield without flooding referral centers?